Drug Development

Exploring 5 types of intellectual property protections in pharma

April 16, 2024 - The Journal of Advanced Pharmaceutical Technology & Research defines intellectual property as “any original creation of the human intellect such as artistic, literary, technical, or scientific creation.” Intellectual property rights or protections are offered to inventors, creators, or owners of particular intellectual property for a specified period, preventing others...

Read More


More Articles

Strategies for engaging, managing KOLs in the pharma industry

by Veronica Salib

Key opinion leaders (KOLs) are healthcare providers (HCPs) and industry leaders who play a critical role in the healthcare industry, acting as vital stakeholders for the sector, including life sciences and pharmaceutical companies....

Walgreens Specialty Pharmacy leads RVVC care with VIVJOA exclusivity

by Alivia Kaylor

In a move set to revolutionize treatment options for post-menopausal women and those not of reproductive potential, Walgreens specialty pharmacy patients now have exclusive access to VIVJOA, an...

Tailoring medication selection with pharmacogenomic testing

by Alivia Kaylor

In modern healthcare, pharmacogenomic assessments are helping healthcare providers determine medication selection, ensuring tailored treatment plans for everyone’s unique genetic makeup. Pharmacogenomic Testing Drug–gene...

Understanding HIV drug resistance, implications for treatment strategies

by Alivia Kaylor

For HIV treatment, the emergence of drug resistance poses a significant challenge. Despite remarkable advancements in antiretroviral therapy (ART), the persistence of HIV in the body and its ability to mutate presents a constant threat to...

AstraZeneca acquires Fusion Pharmaceuticals in $2 billion deal

by Veronica Salib

On March 19, 2024, AstraZeneca entered into a definitive agreement to acquire Fusion Pharmaceuticals in a $2 billion deal. Through this deal, AstraZeneca will expand its portfolio and gain access to...

Manufacturing complex pharmaceutical products with new technologies

by Veronica Salib

Scientific advancement and increasingly complex pharmaceutical products have reshaped the healthcare industry, providing novel tools and solutions for managing broad conditions, from acute viral infections to chronic diseases to oncology....

Continuous Manufacturing Revolutionizes Pharmaceutical Production

by Alivia Kaylor

In the pharmaceutical sector, continuous manufacturing (CM) has emerged as a transformative technology with the potential to revolutionize the industry. As drugmakers seek to enhance efficiency, reduce costs, and ensure a resilient supply...

Novo Nordisk Launches Vaccine Initiative for Airborne Infections

by Veronica Salib

In an announcement published on December 18, 2023, Novo Nordisk, headquartered in Copenhagen, Denmark, announced its plans to allocate $260 million to research and develop vaccines for airborne...

Combating Specialty Drug Challenges in the Pharmaceutical Industry

by Editorial Staff

The pharmaceutical industry has witnessed a significant rise in the utilization of specialty drugs in recent years, prompting a need for improved cost management and a streamlined patient experience. Specialty drugs, characterized by their...

Roche Expands Obesity Portfolio Through $2.7 Billion Carmot Acquisition

by Veronica Salib

On December 4, 2023, Roche revealed that it entered into definitive merger agreements with Carmot Therapeutics. According to the company’s press release, it will acquire Carmot and its gamut of...

FDA Approves Truqap, Faslodex for HR-Positive Breast Cancer

by Veronica Salib

On November 16, 2023, the United States Food and Drug Administration approved AstraZeneca’s Truqap (capivasertib) to be administered in combination with fulvestrant for adults with hormone...

Are Therapeutic Advancements Impacting the Demand for Surgery?

by Veronica Salib

According to the 2023 Trilliant Health report on trends shaping the health economy, the overall demand for surgical procedures has declined from 2017 to 2021. Despite declining rates of surgical interventions, the national disease burden...

Evaluating the Breast Cancer Therapeutics Market

by Veronica Salib

As breast cancer awareness month continues, gathering a comprehensive understanding of the breast cancer therapeutics market is critical, including current trends and market players, gaps, and predictions for the coming year. Understanding...

Ensuring Drug Safety Through Regulatory Compliance

by Alivia Kaylor

In healthcare technology, the intersection of science and regulations is where innovation meets responsibility. Nowhere is this more evident than in the pharmaceutical industry, where drug safety is paramount. Regulatory compliance plays a...

FDA Issues Guidance on Drug Development for Stimulant Use Disorders

by Veronica Salib

On October 4, 2023, the United States Food and Drug Administration (FDA) released a draft guidance titled Stimulant Use Disorders: Developing Drugs for Treatment. The recommendations suggest protocols...

The Importance of Accurately Measuring the Value of New Medications

by Veronica Salib

Last month, No Patient Left Behind, an American nonprofit organization pushing for healthcare reform in the United States to make drugs more affordable, published a report assessing the accuracy and utility of current cost-effectiveness...

How Can Pharmaceutical Companies Meet Drug Launch Expectations

by Veronica Salib

Earlier this month, Deloitte published a report evaluating why so many drug launches failed to meet their expectations. According to data analyzed by the Deloitte Center for Health Solutions through the Life Sciences and Healthcare...

Understanding Implications of Pharmacogenomic on Prescribing

by Veronica Salib

Pharmacogenomic research explores how specific genes or genetic variations can impact drug responses and treatment outcomes. While not a standard of care, pharmacogenomic testing can significantly impact prescribing and medication safety....

7 Ways to Increase Pharmaceutical Sustainability

by Alivia Kaylor

The pharmaceutical sector is undeniably indispensable in the global landscape of essential medications. However, beneath the surface lies a harsh reality of environmental devastation and unsustainable practices. A 2019 Lancet report paints...

Recent Articles